3rd Quarter - Termination
STRATEGIC MARKETING INNOVATIONS for ON DEMAND PHARMACEUTICALS, INC.
Income
$20,000
Expenses
—
Terminated
Aug 31, 2022
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Mobile medicine manufacturing
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL E. BERL | — |
| GLENTON THOMAS MANDIGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.